Longitude (Cayman)’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-87,000
| Closed | -$2.5M | – | 24 |
|
|
2024
Q1 | $2.5M | Buy |
87,000
+7,000
| +9% | +$201K | 1.95% | 9 |
|
|
2023
Q4 | $2.62M | Buy |
80,000
+25,000
| +45% | +$820K | 1.52% | 6 |
|
|
2023
Q3 | $1.53M | Buy |
55,000
+9,000
| +20% | +$251K | 0.97% | 10 |
|
|
2023
Q2 | $1.57M | Buy |
46,000
+5,000
| +12% | +$170K | 1.19% | 18 |
|
|
2023
Q1 | $1.23M | Sell |
41,000
-5,000
| -11% | -$150K | 1.08% | 18 |
|
|
2022
Q4 | $1.3M | Buy |
46,000
+10,000
| +28% | +$282K | 1.66% | 9 |
|
|
2022
Q3 | $1.18M | Sell |
36,000
-5,000
| -12% | -$164K | 1.88% | 17 |
|
|
2022
Q2 | $1.29M | Sell |
41,000
-4,000
| -9% | -$126K | 1.92% | 16 |
|
|
2022
Q1 | $2.07M | Buy |
45,000
+1,150
| +3% | +$52.8K | 1.96% | 23 |
|
|
2021
Q4 | $2.69M | Sell |
43,850
-150
| -0.3% | -$9.19K | 1.43% | 22 |
|
|
2021
Q3 | $3.29M | Buy |
44,000
+14,000
| +47% | +$1.05M | 1.45% | 17 |
|
|
2021
Q2 | $2.78M | Sell |
30,000
-6,500
| -18% | -$601K | 1.32% | 23 |
|
|
2021
Q1 | $3.24M | Buy |
36,500
+27,500
| +306% | +$2.44M | 1.24% | 23 |
|
|
2020
Q4 | $839K | Buy |
+9,000
| New | +$839K | 0.4% | 30 |
|